WORLD JOURNAL OF GASTROENTEROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2241218, encodeId=37eb2241218ea, content=这种状态是要被拒了嘛，求求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/640af84f17e143f993e59237fc1749de-w5VPsj4goXSW.png, type=image, width=1045, height=484)], authenticateStatus=null, createdAvatar=null, createdBy=9bd39563237, createdName=ms2000001469182813, createdTime=Sat Dec 07 12:46:20 CST 2024, time=2024-12-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244654, encodeId=5dca224465469, content=偏重的研究方向：肝硬化 经验分享：WJG返修回，能再增加一个通讯作者么，这个会不会被杂志拒稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4AEFTDxtTLcicl4SBQst8KS16TvccEdKUdYlCe0Rsu73iaW3GgcO1wZmD6PDPwf4a9kadNYiaTic1iadbgAicWWgFzBQ/132, createdBy=026e2391043, createdName=lialunxi, createdTime=Tue Dec 24 13:59:40 CST 2024, time=2024-12-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2237816, encodeId=ac83223e8165e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;胃肠道恶性肿瘤;肝癌 经验分享：历时一个月accept 中间约20天审稿和修改过程分享，有想投的可以聊聊，可以提供些帮助 24-11-12 Send Acceptance Letter to Author 24-11-09 Submit the Revised Manuscript 24-11-06 Author Accepts to Revise 24-10-30 Return the Manuscript to Author for Revision 24-10-30 Made First Decision by Executive Editor-in-Chief 24-10-30 Accept First Decision by Executive Editor-in-Chief 24-10-29 Send to Executive Editor-in-Chief for First Decision 24-10-29 Accept First Decision by Science Editor 24-10-29 Decline First Decision by Science Editor 24-10-12 Submit the Manuscript 24-10-12 Confirm the Receipt and Make General Assessment 24-10-12 Send to Science Editor for Manuscript Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/2f41f69ff42a4be5a4d50af463adba41-wSw7EsGPmncF.jpg, createdBy=3dca9541146, createdName=SCIweichu1是V, createdTime=Tue Nov 19 16:43:15 CST 2024, time=2024-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567000, encodeId=7c9956e0002c, content=投的综述目前两个审稿人意见回来了，都是小修，但1个科学性B语言B，另一个科学性C，语言B。会不会拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c92198239, createdName=120aafd2m69(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2238092, encodeId=3c1022380920c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：消化病 经验分享：投稿过程还是比较顺利和规范的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=406c8423921, createdName=ms5000001572604282, createdTime=Thu Nov 21 00:50:01 CST 2024, time=2024-11-21, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2227562, encodeId=44e7222e56227, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：6月份投稿，一直就是AI在寻找审稿人，添加了200多个，到了九月，终于找到一个，审稿人的意见也很搞笑，就是把我文章里自己写的不足之处复制了一遍，最后意见“小修”，本来以为有戏了，后来编辑部直接就给拒了，理由是他们接收的要求是三个审稿人至少达到ABB的评分以上（另外两位在哪？），编辑部对论文的评价也是一模一样的把我文中的不足之处复制了一遍，感觉审稿人和编辑部也根本就没有认真看文章，拒了以后让你改投他旗下的垃圾杂志。要是觉得我文章质量差大可以初审的时候直接拒掉，等了三个月的外审，期间发了无数邮件，一封也没有回，最后来这出，总之是个大坑杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Sep 25 08:50:54 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2216362, encodeId=ef1f2216362f6, content=偏重的研究方向：胃肠道 经验分享：第一次投WJG，15天反馈了一个审稿人意见，再10天后编辑让大修后转投world j clin oncol，说可以直接接受，查了下WJCO非SCI收录，遂放弃…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:11:27 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2140779, encodeId=69ea2140e7979, content=case report 已经两周了，加了32个审稿人，一点动静都没有，请问这个审稿意见是只能在邮箱里看吗，还是网站上也能查询到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=014a8661100, createdName=ms2000000221922938, createdTime=Sun Jun 04 16:37:15 CST 2023, time=2023-06-04, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2233524, encodeId=35e92233524d4, content=这个期刊太无语了，投了四个月邀请了400多个审稿人，还找不到审稿人，唉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Sun Oct 27 23:09:58 CST 2024, time=2024-10-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2224833, encodeId=0a9f222483331, content=6.4投稿，到现在就回来一个意见，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c176422075, createdName=ms9000000770455842, createdTime=Mon Sep 09 14:38:28 CST 2024, time=2024-09-09, status=1, ipAttribution=江苏省)]

2024-12-07 ms2000001469182813 来自北京

精彩评论，需要您登录查看

13 11

[GetPortalCommentsPageByObjectIdResponse(id=2241218, encodeId=37eb2241218ea, content=这种状态是要被拒了嘛，求求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/640af84f17e143f993e59237fc1749de-w5VPsj4goXSW.png, type=image, width=1045, height=484)], authenticateStatus=null, createdAvatar=null, createdBy=9bd39563237, createdName=ms2000001469182813, createdTime=Sat Dec 07 12:46:20 CST 2024, time=2024-12-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244654, encodeId=5dca224465469, content=偏重的研究方向：肝硬化 经验分享：WJG返修回，能再增加一个通讯作者么，这个会不会被杂志拒稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4AEFTDxtTLcicl4SBQst8KS16TvccEdKUdYlCe0Rsu73iaW3GgcO1wZmD6PDPwf4a9kadNYiaTic1iadbgAicWWgFzBQ/132, createdBy=026e2391043, createdName=lialunxi, createdTime=Tue Dec 24 13:59:40 CST 2024, time=2024-12-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2237816, encodeId=ac83223e8165e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;胃肠道恶性肿瘤;肝癌 经验分享：历时一个月accept 中间约20天审稿和修改过程分享，有想投的可以聊聊，可以提供些帮助 24-11-12 Send Acceptance Letter to Author 24-11-09 Submit the Revised Manuscript 24-11-06 Author Accepts to Revise 24-10-30 Return the Manuscript to Author for Revision 24-10-30 Made First Decision by Executive Editor-in-Chief 24-10-30 Accept First Decision by Executive Editor-in-Chief 24-10-29 Send to Executive Editor-in-Chief for First Decision 24-10-29 Accept First Decision by Science Editor 24-10-29 Decline First Decision by Science Editor 24-10-12 Submit the Manuscript 24-10-12 Confirm the Receipt and Make General Assessment 24-10-12 Send to Science Editor for Manuscript Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/2f41f69ff42a4be5a4d50af463adba41-wSw7EsGPmncF.jpg, createdBy=3dca9541146, createdName=SCIweichu1是V, createdTime=Tue Nov 19 16:43:15 CST 2024, time=2024-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567000, encodeId=7c9956e0002c, content=投的综述目前两个审稿人意见回来了，都是小修，但1个科学性B语言B，另一个科学性C，语言B。会不会拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c92198239, createdName=120aafd2m69(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2238092, encodeId=3c1022380920c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：消化病 经验分享：投稿过程还是比较顺利和规范的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=406c8423921, createdName=ms5000001572604282, createdTime=Thu Nov 21 00:50:01 CST 2024, time=2024-11-21, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2227562, encodeId=44e7222e56227, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：6月份投稿，一直就是AI在寻找审稿人，添加了200多个，到了九月，终于找到一个，审稿人的意见也很搞笑，就是把我文章里自己写的不足之处复制了一遍，最后意见“小修”，本来以为有戏了，后来编辑部直接就给拒了，理由是他们接收的要求是三个审稿人至少达到ABB的评分以上（另外两位在哪？），编辑部对论文的评价也是一模一样的把我文中的不足之处复制了一遍，感觉审稿人和编辑部也根本就没有认真看文章，拒了以后让你改投他旗下的垃圾杂志。要是觉得我文章质量差大可以初审的时候直接拒掉，等了三个月的外审，期间发了无数邮件，一封也没有回，最后来这出，总之是个大坑杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Sep 25 08:50:54 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2216362, encodeId=ef1f2216362f6, content=偏重的研究方向：胃肠道 经验分享：第一次投WJG，15天反馈了一个审稿人意见，再10天后编辑让大修后转投world j clin oncol，说可以直接接受，查了下WJCO非SCI收录，遂放弃…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:11:27 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2140779, encodeId=69ea2140e7979, content=case report 已经两周了，加了32个审稿人，一点动静都没有，请问这个审稿意见是只能在邮箱里看吗，还是网站上也能查询到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=014a8661100, createdName=ms2000000221922938, createdTime=Sun Jun 04 16:37:15 CST 2023, time=2023-06-04, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2233524, encodeId=35e92233524d4, content=这个期刊太无语了，投了四个月邀请了400多个审稿人，还找不到审稿人，唉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Sun Oct 27 23:09:58 CST 2024, time=2024-10-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2224833, encodeId=0a9f222483331, content=6.4投稿，到现在就回来一个意见，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c176422075, createdName=ms9000000770455842, createdTime=Mon Sep 09 14:38:28 CST 2024, time=2024-09-09, status=1, ipAttribution=江苏省)]

2024-12-24 lialunxi 来自广东省

偏重的研究方向：肝硬化
经验分享：WJG返修回，能再增加一个通讯作者么，这个会不会被杂志拒稿呢

1 0

[GetPortalCommentsPageByObjectIdResponse(id=2241218, encodeId=37eb2241218ea, content=这种状态是要被拒了嘛，求求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/640af84f17e143f993e59237fc1749de-w5VPsj4goXSW.png, type=image, width=1045, height=484)], authenticateStatus=null, createdAvatar=null, createdBy=9bd39563237, createdName=ms2000001469182813, createdTime=Sat Dec 07 12:46:20 CST 2024, time=2024-12-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244654, encodeId=5dca224465469, content=偏重的研究方向：肝硬化 经验分享：WJG返修回，能再增加一个通讯作者么，这个会不会被杂志拒稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4AEFTDxtTLcicl4SBQst8KS16TvccEdKUdYlCe0Rsu73iaW3GgcO1wZmD6PDPwf4a9kadNYiaTic1iadbgAicWWgFzBQ/132, createdBy=026e2391043, createdName=lialunxi, createdTime=Tue Dec 24 13:59:40 CST 2024, time=2024-12-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2237816, encodeId=ac83223e8165e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;胃肠道恶性肿瘤;肝癌 经验分享：历时一个月accept 中间约20天审稿和修改过程分享，有想投的可以聊聊，可以提供些帮助 24-11-12 Send Acceptance Letter to Author 24-11-09 Submit the Revised Manuscript 24-11-06 Author Accepts to Revise 24-10-30 Return the Manuscript to Author for Revision 24-10-30 Made First Decision by Executive Editor-in-Chief 24-10-30 Accept First Decision by Executive Editor-in-Chief 24-10-29 Send to Executive Editor-in-Chief for First Decision 24-10-29 Accept First Decision by Science Editor 24-10-29 Decline First Decision by Science Editor 24-10-12 Submit the Manuscript 24-10-12 Confirm the Receipt and Make General Assessment 24-10-12 Send to Science Editor for Manuscript Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/2f41f69ff42a4be5a4d50af463adba41-wSw7EsGPmncF.jpg, createdBy=3dca9541146, createdName=SCIweichu1是V, createdTime=Tue Nov 19 16:43:15 CST 2024, time=2024-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567000, encodeId=7c9956e0002c, content=投的综述目前两个审稿人意见回来了，都是小修，但1个科学性B语言B，另一个科学性C，语言B。会不会拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c92198239, createdName=120aafd2m69(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2238092, encodeId=3c1022380920c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：消化病 经验分享：投稿过程还是比较顺利和规范的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=406c8423921, createdName=ms5000001572604282, createdTime=Thu Nov 21 00:50:01 CST 2024, time=2024-11-21, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2227562, encodeId=44e7222e56227, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：6月份投稿，一直就是AI在寻找审稿人，添加了200多个，到了九月，终于找到一个，审稿人的意见也很搞笑，就是把我文章里自己写的不足之处复制了一遍，最后意见“小修”，本来以为有戏了，后来编辑部直接就给拒了，理由是他们接收的要求是三个审稿人至少达到ABB的评分以上（另外两位在哪？），编辑部对论文的评价也是一模一样的把我文中的不足之处复制了一遍，感觉审稿人和编辑部也根本就没有认真看文章，拒了以后让你改投他旗下的垃圾杂志。要是觉得我文章质量差大可以初审的时候直接拒掉，等了三个月的外审，期间发了无数邮件，一封也没有回，最后来这出，总之是个大坑杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Sep 25 08:50:54 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2216362, encodeId=ef1f2216362f6, content=偏重的研究方向：胃肠道 经验分享：第一次投WJG，15天反馈了一个审稿人意见，再10天后编辑让大修后转投world j clin oncol，说可以直接接受，查了下WJCO非SCI收录，遂放弃…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:11:27 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2140779, encodeId=69ea2140e7979, content=case report 已经两周了，加了32个审稿人，一点动静都没有，请问这个审稿意见是只能在邮箱里看吗，还是网站上也能查询到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=014a8661100, createdName=ms2000000221922938, createdTime=Sun Jun 04 16:37:15 CST 2023, time=2023-06-04, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2233524, encodeId=35e92233524d4, content=这个期刊太无语了，投了四个月邀请了400多个审稿人，还找不到审稿人，唉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Sun Oct 27 23:09:58 CST 2024, time=2024-10-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2224833, encodeId=0a9f222483331, content=6.4投稿，到现在就回来一个意见，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c176422075, createdName=ms9000000770455842, createdTime=Mon Sep 09 14:38:28 CST 2024, time=2024-09-09, status=1, ipAttribution=江苏省)]

2024-11-19 SCIweichu1是V

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;胃肠道恶性肿瘤;肝癌
经验分享：历时一个月accept 中间约20天审稿和修改过程分享，有想投的可以聊聊，可以提供些帮助 24-11-12 Send Acceptance Letter to Author 24-11-09 Submit the Revised Manuscript 24-11-06 Author Accepts to Revise 24-10-30 Return the Manuscript to Author for Revision 24-10-30 Made First Decision by Executive Editor-in-Chief 24-10-30 Accept First Decision by Executive Editor-in-Chief 24-10-29 Send to Executive Editor-in-Chief for First Decision 24-10-29 Accept First Decision by Science Editor 24-10-29 Decline First Decision by Science Editor 24-10-12 Submit the Manuscript 24-10-12 Confirm the Receipt and Make General Assessment 24-10-12 Send to Science Editor for Manuscript Review

89 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2241218, encodeId=37eb2241218ea, content=这种状态是要被拒了嘛，求求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/640af84f17e143f993e59237fc1749de-w5VPsj4goXSW.png, type=image, width=1045, height=484)], authenticateStatus=null, createdAvatar=null, createdBy=9bd39563237, createdName=ms2000001469182813, createdTime=Sat Dec 07 12:46:20 CST 2024, time=2024-12-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244654, encodeId=5dca224465469, content=偏重的研究方向：肝硬化 经验分享：WJG返修回，能再增加一个通讯作者么，这个会不会被杂志拒稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4AEFTDxtTLcicl4SBQst8KS16TvccEdKUdYlCe0Rsu73iaW3GgcO1wZmD6PDPwf4a9kadNYiaTic1iadbgAicWWgFzBQ/132, createdBy=026e2391043, createdName=lialunxi, createdTime=Tue Dec 24 13:59:40 CST 2024, time=2024-12-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2237816, encodeId=ac83223e8165e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;胃肠道恶性肿瘤;肝癌 经验分享：历时一个月accept 中间约20天审稿和修改过程分享，有想投的可以聊聊，可以提供些帮助 24-11-12 Send Acceptance Letter to Author 24-11-09 Submit the Revised Manuscript 24-11-06 Author Accepts to Revise 24-10-30 Return the Manuscript to Author for Revision 24-10-30 Made First Decision by Executive Editor-in-Chief 24-10-30 Accept First Decision by Executive Editor-in-Chief 24-10-29 Send to Executive Editor-in-Chief for First Decision 24-10-29 Accept First Decision by Science Editor 24-10-29 Decline First Decision by Science Editor 24-10-12 Submit the Manuscript 24-10-12 Confirm the Receipt and Make General Assessment 24-10-12 Send to Science Editor for Manuscript Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/2f41f69ff42a4be5a4d50af463adba41-wSw7EsGPmncF.jpg, createdBy=3dca9541146, createdName=SCIweichu1是V, createdTime=Tue Nov 19 16:43:15 CST 2024, time=2024-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567000, encodeId=7c9956e0002c, content=投的综述目前两个审稿人意见回来了，都是小修，但1个科学性B语言B，另一个科学性C，语言B。会不会拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c92198239, createdName=120aafd2m69(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2238092, encodeId=3c1022380920c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：消化病 经验分享：投稿过程还是比较顺利和规范的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=406c8423921, createdName=ms5000001572604282, createdTime=Thu Nov 21 00:50:01 CST 2024, time=2024-11-21, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2227562, encodeId=44e7222e56227, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：6月份投稿，一直就是AI在寻找审稿人，添加了200多个，到了九月，终于找到一个，审稿人的意见也很搞笑，就是把我文章里自己写的不足之处复制了一遍，最后意见“小修”，本来以为有戏了，后来编辑部直接就给拒了，理由是他们接收的要求是三个审稿人至少达到ABB的评分以上（另外两位在哪？），编辑部对论文的评价也是一模一样的把我文中的不足之处复制了一遍，感觉审稿人和编辑部也根本就没有认真看文章，拒了以后让你改投他旗下的垃圾杂志。要是觉得我文章质量差大可以初审的时候直接拒掉，等了三个月的外审，期间发了无数邮件，一封也没有回，最后来这出，总之是个大坑杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Sep 25 08:50:54 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2216362, encodeId=ef1f2216362f6, content=偏重的研究方向：胃肠道 经验分享：第一次投WJG，15天反馈了一个审稿人意见，再10天后编辑让大修后转投world j clin oncol，说可以直接接受，查了下WJCO非SCI收录，遂放弃…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:11:27 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2140779, encodeId=69ea2140e7979, content=case report 已经两周了，加了32个审稿人，一点动静都没有，请问这个审稿意见是只能在邮箱里看吗，还是网站上也能查询到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=014a8661100, createdName=ms2000000221922938, createdTime=Sun Jun 04 16:37:15 CST 2023, time=2023-06-04, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2233524, encodeId=35e92233524d4, content=这个期刊太无语了，投了四个月邀请了400多个审稿人，还找不到审稿人，唉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Sun Oct 27 23:09:58 CST 2024, time=2024-10-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2224833, encodeId=0a9f222483331, content=6.4投稿，到现在就回来一个意见，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c176422075, createdName=ms9000000770455842, createdTime=Mon Sep 09 14:38:28 CST 2024, time=2024-09-09, status=1, ipAttribution=江苏省)]

2019-02-20 120aafd2m69(暂无昵称)

投的综述目前两个审稿人意见回来了，都是小修，但1个科学性B语言B，另一个科学性C，语言B。会不会拒稿啊？

410 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2241218, encodeId=37eb2241218ea, content=这种状态是要被拒了嘛，求求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/640af84f17e143f993e59237fc1749de-w5VPsj4goXSW.png, type=image, width=1045, height=484)], authenticateStatus=null, createdAvatar=null, createdBy=9bd39563237, createdName=ms2000001469182813, createdTime=Sat Dec 07 12:46:20 CST 2024, time=2024-12-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244654, encodeId=5dca224465469, content=偏重的研究方向：肝硬化 经验分享：WJG返修回，能再增加一个通讯作者么，这个会不会被杂志拒稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4AEFTDxtTLcicl4SBQst8KS16TvccEdKUdYlCe0Rsu73iaW3GgcO1wZmD6PDPwf4a9kadNYiaTic1iadbgAicWWgFzBQ/132, createdBy=026e2391043, createdName=lialunxi, createdTime=Tue Dec 24 13:59:40 CST 2024, time=2024-12-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2237816, encodeId=ac83223e8165e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;胃肠道恶性肿瘤;肝癌 经验分享：历时一个月accept 中间约20天审稿和修改过程分享，有想投的可以聊聊，可以提供些帮助 24-11-12 Send Acceptance Letter to Author 24-11-09 Submit the Revised Manuscript 24-11-06 Author Accepts to Revise 24-10-30 Return the Manuscript to Author for Revision 24-10-30 Made First Decision by Executive Editor-in-Chief 24-10-30 Accept First Decision by Executive Editor-in-Chief 24-10-29 Send to Executive Editor-in-Chief for First Decision 24-10-29 Accept First Decision by Science Editor 24-10-29 Decline First Decision by Science Editor 24-10-12 Submit the Manuscript 24-10-12 Confirm the Receipt and Make General Assessment 24-10-12 Send to Science Editor for Manuscript Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/2f41f69ff42a4be5a4d50af463adba41-wSw7EsGPmncF.jpg, createdBy=3dca9541146, createdName=SCIweichu1是V, createdTime=Tue Nov 19 16:43:15 CST 2024, time=2024-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567000, encodeId=7c9956e0002c, content=投的综述目前两个审稿人意见回来了，都是小修，但1个科学性B语言B，另一个科学性C，语言B。会不会拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c92198239, createdName=120aafd2m69(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2238092, encodeId=3c1022380920c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：消化病 经验分享：投稿过程还是比较顺利和规范的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=406c8423921, createdName=ms5000001572604282, createdTime=Thu Nov 21 00:50:01 CST 2024, time=2024-11-21, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2227562, encodeId=44e7222e56227, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：6月份投稿，一直就是AI在寻找审稿人，添加了200多个，到了九月，终于找到一个，审稿人的意见也很搞笑，就是把我文章里自己写的不足之处复制了一遍，最后意见“小修”，本来以为有戏了，后来编辑部直接就给拒了，理由是他们接收的要求是三个审稿人至少达到ABB的评分以上（另外两位在哪？），编辑部对论文的评价也是一模一样的把我文中的不足之处复制了一遍，感觉审稿人和编辑部也根本就没有认真看文章，拒了以后让你改投他旗下的垃圾杂志。要是觉得我文章质量差大可以初审的时候直接拒掉，等了三个月的外审，期间发了无数邮件，一封也没有回，最后来这出，总之是个大坑杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Sep 25 08:50:54 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2216362, encodeId=ef1f2216362f6, content=偏重的研究方向：胃肠道 经验分享：第一次投WJG，15天反馈了一个审稿人意见，再10天后编辑让大修后转投world j clin oncol，说可以直接接受，查了下WJCO非SCI收录，遂放弃…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:11:27 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2140779, encodeId=69ea2140e7979, content=case report 已经两周了，加了32个审稿人，一点动静都没有，请问这个审稿意见是只能在邮箱里看吗，还是网站上也能查询到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=014a8661100, createdName=ms2000000221922938, createdTime=Sun Jun 04 16:37:15 CST 2023, time=2023-06-04, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2233524, encodeId=35e92233524d4, content=这个期刊太无语了，投了四个月邀请了400多个审稿人，还找不到审稿人，唉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Sun Oct 27 23:09:58 CST 2024, time=2024-10-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2224833, encodeId=0a9f222483331, content=6.4投稿，到现在就回来一个意见，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c176422075, createdName=ms9000000770455842, createdTime=Mon Sep 09 14:38:28 CST 2024, time=2024-09-09, status=1, ipAttribution=江苏省)]

2024-11-21 ms5000001572604282 来自吉林省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：消化病
经验分享：投稿过程还是比较顺利和规范的

25 0

[GetPortalCommentsPageByObjectIdResponse(id=2241218, encodeId=37eb2241218ea, content=这种状态是要被拒了嘛，求求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/640af84f17e143f993e59237fc1749de-w5VPsj4goXSW.png, type=image, width=1045, height=484)], authenticateStatus=null, createdAvatar=null, createdBy=9bd39563237, createdName=ms2000001469182813, createdTime=Sat Dec 07 12:46:20 CST 2024, time=2024-12-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244654, encodeId=5dca224465469, content=偏重的研究方向：肝硬化 经验分享：WJG返修回，能再增加一个通讯作者么，这个会不会被杂志拒稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4AEFTDxtTLcicl4SBQst8KS16TvccEdKUdYlCe0Rsu73iaW3GgcO1wZmD6PDPwf4a9kadNYiaTic1iadbgAicWWgFzBQ/132, createdBy=026e2391043, createdName=lialunxi, createdTime=Tue Dec 24 13:59:40 CST 2024, time=2024-12-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2237816, encodeId=ac83223e8165e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;胃肠道恶性肿瘤;肝癌 经验分享：历时一个月accept 中间约20天审稿和修改过程分享，有想投的可以聊聊，可以提供些帮助 24-11-12 Send Acceptance Letter to Author 24-11-09 Submit the Revised Manuscript 24-11-06 Author Accepts to Revise 24-10-30 Return the Manuscript to Author for Revision 24-10-30 Made First Decision by Executive Editor-in-Chief 24-10-30 Accept First Decision by Executive Editor-in-Chief 24-10-29 Send to Executive Editor-in-Chief for First Decision 24-10-29 Accept First Decision by Science Editor 24-10-29 Decline First Decision by Science Editor 24-10-12 Submit the Manuscript 24-10-12 Confirm the Receipt and Make General Assessment 24-10-12 Send to Science Editor for Manuscript Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/2f41f69ff42a4be5a4d50af463adba41-wSw7EsGPmncF.jpg, createdBy=3dca9541146, createdName=SCIweichu1是V, createdTime=Tue Nov 19 16:43:15 CST 2024, time=2024-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567000, encodeId=7c9956e0002c, content=投的综述目前两个审稿人意见回来了，都是小修，但1个科学性B语言B，另一个科学性C，语言B。会不会拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c92198239, createdName=120aafd2m69(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2238092, encodeId=3c1022380920c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：消化病 经验分享：投稿过程还是比较顺利和规范的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=406c8423921, createdName=ms5000001572604282, createdTime=Thu Nov 21 00:50:01 CST 2024, time=2024-11-21, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2227562, encodeId=44e7222e56227, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：6月份投稿，一直就是AI在寻找审稿人，添加了200多个，到了九月，终于找到一个，审稿人的意见也很搞笑，就是把我文章里自己写的不足之处复制了一遍，最后意见“小修”，本来以为有戏了，后来编辑部直接就给拒了，理由是他们接收的要求是三个审稿人至少达到ABB的评分以上（另外两位在哪？），编辑部对论文的评价也是一模一样的把我文中的不足之处复制了一遍，感觉审稿人和编辑部也根本就没有认真看文章，拒了以后让你改投他旗下的垃圾杂志。要是觉得我文章质量差大可以初审的时候直接拒掉，等了三个月的外审，期间发了无数邮件，一封也没有回，最后来这出，总之是个大坑杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Sep 25 08:50:54 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2216362, encodeId=ef1f2216362f6, content=偏重的研究方向：胃肠道 经验分享：第一次投WJG，15天反馈了一个审稿人意见，再10天后编辑让大修后转投world j clin oncol，说可以直接接受，查了下WJCO非SCI收录，遂放弃…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:11:27 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2140779, encodeId=69ea2140e7979, content=case report 已经两周了，加了32个审稿人，一点动静都没有，请问这个审稿意见是只能在邮箱里看吗，还是网站上也能查询到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=014a8661100, createdName=ms2000000221922938, createdTime=Sun Jun 04 16:37:15 CST 2023, time=2023-06-04, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2233524, encodeId=35e92233524d4, content=这个期刊太无语了，投了四个月邀请了400多个审稿人，还找不到审稿人，唉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Sun Oct 27 23:09:58 CST 2024, time=2024-10-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2224833, encodeId=0a9f222483331, content=6.4投稿，到现在就回来一个意见，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c176422075, createdName=ms9000000770455842, createdTime=Mon Sep 09 14:38:28 CST 2024, time=2024-09-09, status=1, ipAttribution=江苏省)]

2024-09-25 493473315 来自安徽省

审稿速度:12.0 | 投稿命中率:5.0
经验分享：6月份投稿，一直就是AI在寻找审稿人，添加了200多个，到了九月，终于找到一个，审稿人的意见也很搞笑，就是把我文章里自己写的不足之处复制了一遍，最后意见“小修”，本来以为有戏了，后来编辑部直接就给拒了，理由是他们接收的要求是三个审稿人至少达到ABB的评分以上（另外两位在哪？），编辑部对论文的评价也是一模一样的把我文中的不足之处复制了一遍，感觉审稿人和编辑部也根本就没有认真看文章，拒了以后让你改投他旗下的垃圾杂志。要是觉得我文章质量差大可以初审的时候直接拒掉，等了三个月的外审，期间发了无数邮件，一封也没有回，最后来这出，总之是个大坑杂志

38 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2241218, encodeId=37eb2241218ea, content=这种状态是要被拒了嘛，求求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/640af84f17e143f993e59237fc1749de-w5VPsj4goXSW.png, type=image, width=1045, height=484)], authenticateStatus=null, createdAvatar=null, createdBy=9bd39563237, createdName=ms2000001469182813, createdTime=Sat Dec 07 12:46:20 CST 2024, time=2024-12-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244654, encodeId=5dca224465469, content=偏重的研究方向：肝硬化 经验分享：WJG返修回，能再增加一个通讯作者么，这个会不会被杂志拒稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4AEFTDxtTLcicl4SBQst8KS16TvccEdKUdYlCe0Rsu73iaW3GgcO1wZmD6PDPwf4a9kadNYiaTic1iadbgAicWWgFzBQ/132, createdBy=026e2391043, createdName=lialunxi, createdTime=Tue Dec 24 13:59:40 CST 2024, time=2024-12-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2237816, encodeId=ac83223e8165e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;胃肠道恶性肿瘤;肝癌 经验分享：历时一个月accept 中间约20天审稿和修改过程分享，有想投的可以聊聊，可以提供些帮助 24-11-12 Send Acceptance Letter to Author 24-11-09 Submit the Revised Manuscript 24-11-06 Author Accepts to Revise 24-10-30 Return the Manuscript to Author for Revision 24-10-30 Made First Decision by Executive Editor-in-Chief 24-10-30 Accept First Decision by Executive Editor-in-Chief 24-10-29 Send to Executive Editor-in-Chief for First Decision 24-10-29 Accept First Decision by Science Editor 24-10-29 Decline First Decision by Science Editor 24-10-12 Submit the Manuscript 24-10-12 Confirm the Receipt and Make General Assessment 24-10-12 Send to Science Editor for Manuscript Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/2f41f69ff42a4be5a4d50af463adba41-wSw7EsGPmncF.jpg, createdBy=3dca9541146, createdName=SCIweichu1是V, createdTime=Tue Nov 19 16:43:15 CST 2024, time=2024-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567000, encodeId=7c9956e0002c, content=投的综述目前两个审稿人意见回来了，都是小修，但1个科学性B语言B，另一个科学性C，语言B。会不会拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c92198239, createdName=120aafd2m69(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2238092, encodeId=3c1022380920c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：消化病 经验分享：投稿过程还是比较顺利和规范的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=406c8423921, createdName=ms5000001572604282, createdTime=Thu Nov 21 00:50:01 CST 2024, time=2024-11-21, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2227562, encodeId=44e7222e56227, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：6月份投稿，一直就是AI在寻找审稿人，添加了200多个，到了九月，终于找到一个，审稿人的意见也很搞笑，就是把我文章里自己写的不足之处复制了一遍，最后意见“小修”，本来以为有戏了，后来编辑部直接就给拒了，理由是他们接收的要求是三个审稿人至少达到ABB的评分以上（另外两位在哪？），编辑部对论文的评价也是一模一样的把我文中的不足之处复制了一遍，感觉审稿人和编辑部也根本就没有认真看文章，拒了以后让你改投他旗下的垃圾杂志。要是觉得我文章质量差大可以初审的时候直接拒掉，等了三个月的外审，期间发了无数邮件，一封也没有回，最后来这出，总之是个大坑杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Sep 25 08:50:54 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2216362, encodeId=ef1f2216362f6, content=偏重的研究方向：胃肠道 经验分享：第一次投WJG，15天反馈了一个审稿人意见，再10天后编辑让大修后转投world j clin oncol，说可以直接接受，查了下WJCO非SCI收录，遂放弃…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:11:27 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2140779, encodeId=69ea2140e7979, content=case report 已经两周了，加了32个审稿人，一点动静都没有，请问这个审稿意见是只能在邮箱里看吗，还是网站上也能查询到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=014a8661100, createdName=ms2000000221922938, createdTime=Sun Jun 04 16:37:15 CST 2023, time=2023-06-04, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2233524, encodeId=35e92233524d4, content=这个期刊太无语了，投了四个月邀请了400多个审稿人，还找不到审稿人，唉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Sun Oct 27 23:09:58 CST 2024, time=2024-10-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2224833, encodeId=0a9f222483331, content=6.4投稿，到现在就回来一个意见，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c176422075, createdName=ms9000000770455842, createdTime=Mon Sep 09 14:38:28 CST 2024, time=2024-09-09, status=1, ipAttribution=江苏省)]

2024-07-22 biocell160 来自贵州省

偏重的研究方向：胃肠道
经验分享：第一次投WJG，15天反馈了一个审稿人意见，再10天后编辑让大修后转投world j clin oncol，说可以直接接受，查了下WJCO非SCI收录，遂放弃…

71 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2241218, encodeId=37eb2241218ea, content=这种状态是要被拒了嘛，求求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/640af84f17e143f993e59237fc1749de-w5VPsj4goXSW.png, type=image, width=1045, height=484)], authenticateStatus=null, createdAvatar=null, createdBy=9bd39563237, createdName=ms2000001469182813, createdTime=Sat Dec 07 12:46:20 CST 2024, time=2024-12-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244654, encodeId=5dca224465469, content=偏重的研究方向：肝硬化 经验分享：WJG返修回，能再增加一个通讯作者么，这个会不会被杂志拒稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4AEFTDxtTLcicl4SBQst8KS16TvccEdKUdYlCe0Rsu73iaW3GgcO1wZmD6PDPwf4a9kadNYiaTic1iadbgAicWWgFzBQ/132, createdBy=026e2391043, createdName=lialunxi, createdTime=Tue Dec 24 13:59:40 CST 2024, time=2024-12-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2237816, encodeId=ac83223e8165e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;胃肠道恶性肿瘤;肝癌 经验分享：历时一个月accept 中间约20天审稿和修改过程分享，有想投的可以聊聊，可以提供些帮助 24-11-12 Send Acceptance Letter to Author 24-11-09 Submit the Revised Manuscript 24-11-06 Author Accepts to Revise 24-10-30 Return the Manuscript to Author for Revision 24-10-30 Made First Decision by Executive Editor-in-Chief 24-10-30 Accept First Decision by Executive Editor-in-Chief 24-10-29 Send to Executive Editor-in-Chief for First Decision 24-10-29 Accept First Decision by Science Editor 24-10-29 Decline First Decision by Science Editor 24-10-12 Submit the Manuscript 24-10-12 Confirm the Receipt and Make General Assessment 24-10-12 Send to Science Editor for Manuscript Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/2f41f69ff42a4be5a4d50af463adba41-wSw7EsGPmncF.jpg, createdBy=3dca9541146, createdName=SCIweichu1是V, createdTime=Tue Nov 19 16:43:15 CST 2024, time=2024-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567000, encodeId=7c9956e0002c, content=投的综述目前两个审稿人意见回来了，都是小修，但1个科学性B语言B，另一个科学性C，语言B。会不会拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c92198239, createdName=120aafd2m69(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2238092, encodeId=3c1022380920c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：消化病 经验分享：投稿过程还是比较顺利和规范的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=406c8423921, createdName=ms5000001572604282, createdTime=Thu Nov 21 00:50:01 CST 2024, time=2024-11-21, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2227562, encodeId=44e7222e56227, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：6月份投稿，一直就是AI在寻找审稿人，添加了200多个，到了九月，终于找到一个，审稿人的意见也很搞笑，就是把我文章里自己写的不足之处复制了一遍，最后意见“小修”，本来以为有戏了，后来编辑部直接就给拒了，理由是他们接收的要求是三个审稿人至少达到ABB的评分以上（另外两位在哪？），编辑部对论文的评价也是一模一样的把我文中的不足之处复制了一遍，感觉审稿人和编辑部也根本就没有认真看文章，拒了以后让你改投他旗下的垃圾杂志。要是觉得我文章质量差大可以初审的时候直接拒掉，等了三个月的外审，期间发了无数邮件，一封也没有回，最后来这出，总之是个大坑杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Sep 25 08:50:54 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2216362, encodeId=ef1f2216362f6, content=偏重的研究方向：胃肠道 经验分享：第一次投WJG，15天反馈了一个审稿人意见，再10天后编辑让大修后转投world j clin oncol，说可以直接接受，查了下WJCO非SCI收录，遂放弃…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:11:27 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2140779, encodeId=69ea2140e7979, content=case report 已经两周了，加了32个审稿人，一点动静都没有，请问这个审稿意见是只能在邮箱里看吗，还是网站上也能查询到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=014a8661100, createdName=ms2000000221922938, createdTime=Sun Jun 04 16:37:15 CST 2023, time=2023-06-04, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2233524, encodeId=35e92233524d4, content=这个期刊太无语了，投了四个月邀请了400多个审稿人，还找不到审稿人，唉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Sun Oct 27 23:09:58 CST 2024, time=2024-10-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2224833, encodeId=0a9f222483331, content=6.4投稿，到现在就回来一个意见，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c176422075, createdName=ms9000000770455842, createdTime=Mon Sep 09 14:38:28 CST 2024, time=2024-09-09, status=1, ipAttribution=江苏省)]

2023-06-04 ms2000000221922938 来自江西省

case report
已经两周了，加了32个审稿人，一点动静都没有，请问这个审稿意见是只能在邮箱里看吗，还是网站上也能查询到呀

107 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2241218, encodeId=37eb2241218ea, content=这种状态是要被拒了嘛，求求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/640af84f17e143f993e59237fc1749de-w5VPsj4goXSW.png, type=image, width=1045, height=484)], authenticateStatus=null, createdAvatar=null, createdBy=9bd39563237, createdName=ms2000001469182813, createdTime=Sat Dec 07 12:46:20 CST 2024, time=2024-12-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244654, encodeId=5dca224465469, content=偏重的研究方向：肝硬化 经验分享：WJG返修回，能再增加一个通讯作者么，这个会不会被杂志拒稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4AEFTDxtTLcicl4SBQst8KS16TvccEdKUdYlCe0Rsu73iaW3GgcO1wZmD6PDPwf4a9kadNYiaTic1iadbgAicWWgFzBQ/132, createdBy=026e2391043, createdName=lialunxi, createdTime=Tue Dec 24 13:59:40 CST 2024, time=2024-12-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2237816, encodeId=ac83223e8165e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;胃肠道恶性肿瘤;肝癌 经验分享：历时一个月accept 中间约20天审稿和修改过程分享，有想投的可以聊聊，可以提供些帮助 24-11-12 Send Acceptance Letter to Author 24-11-09 Submit the Revised Manuscript 24-11-06 Author Accepts to Revise 24-10-30 Return the Manuscript to Author for Revision 24-10-30 Made First Decision by Executive Editor-in-Chief 24-10-30 Accept First Decision by Executive Editor-in-Chief 24-10-29 Send to Executive Editor-in-Chief for First Decision 24-10-29 Accept First Decision by Science Editor 24-10-29 Decline First Decision by Science Editor 24-10-12 Submit the Manuscript 24-10-12 Confirm the Receipt and Make General Assessment 24-10-12 Send to Science Editor for Manuscript Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/2f41f69ff42a4be5a4d50af463adba41-wSw7EsGPmncF.jpg, createdBy=3dca9541146, createdName=SCIweichu1是V, createdTime=Tue Nov 19 16:43:15 CST 2024, time=2024-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567000, encodeId=7c9956e0002c, content=投的综述目前两个审稿人意见回来了，都是小修，但1个科学性B语言B，另一个科学性C，语言B。会不会拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c92198239, createdName=120aafd2m69(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2238092, encodeId=3c1022380920c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：消化病 经验分享：投稿过程还是比较顺利和规范的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=406c8423921, createdName=ms5000001572604282, createdTime=Thu Nov 21 00:50:01 CST 2024, time=2024-11-21, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2227562, encodeId=44e7222e56227, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：6月份投稿，一直就是AI在寻找审稿人，添加了200多个，到了九月，终于找到一个，审稿人的意见也很搞笑，就是把我文章里自己写的不足之处复制了一遍，最后意见“小修”，本来以为有戏了，后来编辑部直接就给拒了，理由是他们接收的要求是三个审稿人至少达到ABB的评分以上（另外两位在哪？），编辑部对论文的评价也是一模一样的把我文中的不足之处复制了一遍，感觉审稿人和编辑部也根本就没有认真看文章，拒了以后让你改投他旗下的垃圾杂志。要是觉得我文章质量差大可以初审的时候直接拒掉，等了三个月的外审，期间发了无数邮件，一封也没有回，最后来这出，总之是个大坑杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Sep 25 08:50:54 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2216362, encodeId=ef1f2216362f6, content=偏重的研究方向：胃肠道 经验分享：第一次投WJG，15天反馈了一个审稿人意见，再10天后编辑让大修后转投world j clin oncol，说可以直接接受，查了下WJCO非SCI收录，遂放弃…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:11:27 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2140779, encodeId=69ea2140e7979, content=case report 已经两周了，加了32个审稿人，一点动静都没有，请问这个审稿意见是只能在邮箱里看吗，还是网站上也能查询到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=014a8661100, createdName=ms2000000221922938, createdTime=Sun Jun 04 16:37:15 CST 2023, time=2023-06-04, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2233524, encodeId=35e92233524d4, content=这个期刊太无语了，投了四个月邀请了400多个审稿人，还找不到审稿人，唉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Sun Oct 27 23:09:58 CST 2024, time=2024-10-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2224833, encodeId=0a9f222483331, content=6.4投稿，到现在就回来一个意见，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c176422075, createdName=ms9000000770455842, createdTime=Mon Sep 09 14:38:28 CST 2024, time=2024-09-09, status=1, ipAttribution=江苏省)]

2024-10-27 ms4000000094701757 来自广东省

这个期刊太无语了，投了四个月邀请了400多个审稿人，还找不到审稿人，唉！

28 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2241218, encodeId=37eb2241218ea, content=这种状态是要被拒了嘛，求求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/640af84f17e143f993e59237fc1749de-w5VPsj4goXSW.png, type=image, width=1045, height=484)], authenticateStatus=null, createdAvatar=null, createdBy=9bd39563237, createdName=ms2000001469182813, createdTime=Sat Dec 07 12:46:20 CST 2024, time=2024-12-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244654, encodeId=5dca224465469, content=偏重的研究方向：肝硬化 经验分享：WJG返修回，能再增加一个通讯作者么，这个会不会被杂志拒稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4AEFTDxtTLcicl4SBQst8KS16TvccEdKUdYlCe0Rsu73iaW3GgcO1wZmD6PDPwf4a9kadNYiaTic1iadbgAicWWgFzBQ/132, createdBy=026e2391043, createdName=lialunxi, createdTime=Tue Dec 24 13:59:40 CST 2024, time=2024-12-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2237816, encodeId=ac83223e8165e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;胃肠道恶性肿瘤;肝癌 经验分享：历时一个月accept 中间约20天审稿和修改过程分享，有想投的可以聊聊，可以提供些帮助 24-11-12 Send Acceptance Letter to Author 24-11-09 Submit the Revised Manuscript 24-11-06 Author Accepts to Revise 24-10-30 Return the Manuscript to Author for Revision 24-10-30 Made First Decision by Executive Editor-in-Chief 24-10-30 Accept First Decision by Executive Editor-in-Chief 24-10-29 Send to Executive Editor-in-Chief for First Decision 24-10-29 Accept First Decision by Science Editor 24-10-29 Decline First Decision by Science Editor 24-10-12 Submit the Manuscript 24-10-12 Confirm the Receipt and Make General Assessment 24-10-12 Send to Science Editor for Manuscript Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/2f41f69ff42a4be5a4d50af463adba41-wSw7EsGPmncF.jpg, createdBy=3dca9541146, createdName=SCIweichu1是V, createdTime=Tue Nov 19 16:43:15 CST 2024, time=2024-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567000, encodeId=7c9956e0002c, content=投的综述目前两个审稿人意见回来了，都是小修，但1个科学性B语言B，另一个科学性C，语言B。会不会拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c92198239, createdName=120aafd2m69(暂无昵称), createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2238092, encodeId=3c1022380920c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：消化病 经验分享：投稿过程还是比较顺利和规范的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=406c8423921, createdName=ms5000001572604282, createdTime=Thu Nov 21 00:50:01 CST 2024, time=2024-11-21, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2227562, encodeId=44e7222e56227, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：6月份投稿，一直就是AI在寻找审稿人，添加了200多个，到了九月，终于找到一个，审稿人的意见也很搞笑，就是把我文章里自己写的不足之处复制了一遍，最后意见“小修”，本来以为有戏了，后来编辑部直接就给拒了，理由是他们接收的要求是三个审稿人至少达到ABB的评分以上（另外两位在哪？），编辑部对论文的评价也是一模一样的把我文中的不足之处复制了一遍，感觉审稿人和编辑部也根本就没有认真看文章，拒了以后让你改投他旗下的垃圾杂志。要是觉得我文章质量差大可以初审的时候直接拒掉，等了三个月的外审，期间发了无数邮件，一封也没有回，最后来这出，总之是个大坑杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Sep 25 08:50:54 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2216362, encodeId=ef1f2216362f6, content=偏重的研究方向：胃肠道 经验分享：第一次投WJG，15天反馈了一个审稿人意见，再10天后编辑让大修后转投world j clin oncol，说可以直接接受，查了下WJCO非SCI收录，遂放弃…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:11:27 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2140779, encodeId=69ea2140e7979, content=case report 已经两周了，加了32个审稿人，一点动静都没有，请问这个审稿意见是只能在邮箱里看吗，还是网站上也能查询到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=014a8661100, createdName=ms2000000221922938, createdTime=Sun Jun 04 16:37:15 CST 2023, time=2023-06-04, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2233524, encodeId=35e92233524d4, content=这个期刊太无语了，投了四个月邀请了400多个审稿人，还找不到审稿人，唉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Sun Oct 27 23:09:58 CST 2024, time=2024-10-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2224833, encodeId=0a9f222483331, content=6.4投稿，到现在就回来一个意见，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c176422075, createdName=ms9000000770455842, createdTime=Mon Sep 09 14:38:28 CST 2024, time=2024-09-09, status=1, ipAttribution=江苏省)]

2024-09-09 ms9000000770455842 来自江苏省

6.4投稿，到现在就回来一个意见，，，

39 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务